Evidence map›Paper›PMID 32227238›Full record

SynthesisEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2020

Predicting recurrent atrial fibrillation after catheter ablation: a systematic review of prognostic models.

Janine Dretzke, Naomi Chuchu, Ridhi Agarwal, Clare Herd, Winnie Chua, Larissa Fabritz, Susan Bayliss, Dipak Kotecha, Jonathan J Deeks, Paulus Kirchhof and 1 more

Registry-linked trialAbstract readSystematic Review
In one paragraph

Synthesis in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07444372 (Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation), which is not on this map. Cited by 85 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07444372 narecruitingnot on this mapstarted 2026, after this paper: background citation

Start CPAP Therapy in Obstructive Sleep Apnea Patients After Atrial Fibrillation Ablation: A Multicenter, Open-label, Randomized Clinical Trial

TypeinterventionalSponsorBeijing Anzhen HospitalRan2026 to 2029Enrolled658ConditionsObstructive Sleep Apnea, Sleep Disorder (Disorder), Atrial Fibrillation (AF), Sleep Disordered Breathing (SDB)ArmsContinuous Positive Airway Pressure (CPAP), Usual Care
3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. P-wave duration and atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Machine learning prediction of outcome following pulsed-field atrial fibrillation ablation: patient selection and risk factors.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Janine DretzkeInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
Naomi ChuchuInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
Ridhi AgarwalInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
Clare HerdInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
Winnie ChuaInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Larissa FabritzInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Susan BaylissInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
Dipak KotechaInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Jonathan J DeeksInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.
Paulus KirchhofInstitute of Cardiovascular Sciences, University of Birmingham, Birmingham B15 2TT, UK.
Yemisi TakwoingiInstitute of Applied Health Research, University of Birmingham, Birmingham B15 2TT, UK.

Funding

British Heart Foundation AA/18/2/34218British Heart Foundation FS/13/43/30324British Heart Foundation PG/17/30/32961Department of Health CDF-2015-08-074
6 · The paper itself

Abstract

aimsWe assessed the performance of modelsf (risk scores) for predicting recurrence of atrial fibrillation (AF) in patients who have undergone catheter ablation. METHODS AND

resultsSystematic searches of bibliographic databases were conducted (November 2018). Studies were eligible for inclusion if they reported the development, validation, or impact assessment of a model for predicting AF recurrence after ablation. Model performance (discrimination and calibration) measures were extracted. The Prediction Study Risk of Bias Assessment Tool (PROBAST) was used to assess risk of bias. Meta-analysis was not feasible due to clinical and methodological differences between studies, but c-statistics were presented in forest plots. Thirty-three studies developing or validating 13 models were included; eight studies compared two or more models. Common model variables were left atrial parameters, type of AF, and age. Model discriminatory ability was highly variable and no model had consistently poor or good performance. Most studies did not assess model calibration. The main risk of bias concern was the lack of internal validation which may have resulted in overly optimistic and/or biased model performance estimates. No model impact studies were identified.

conclusionOur systematic review suggests that clinical risk prediction of AF after ablation has potential, but there remains a need for robust evaluation of risk factors and development of risk scores.

Indexed as

Atrial FibrillationCatheter AblationHeart AtriaHumansPrognosisRecurrenceRisk FactorsTreatment OutcomeAtrial fibrillationCatheter ablationModel performancePrognostic modelRecurrenceSystematic review

Identifiers

PMID32227238
PMCPMC7203634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.